Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for excessive sleepiness in TBI
NCT00983437Phase 3Terminated
- Sponsor
- Cephalon, Inc.
- Start
- Aug 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of armodafinil in Hypersomnia (HS), sponsored by Cephalon, Inc.. Started Aug 2009; status: terminated.
02
Drugs
armodafinil
03
Conditions
Hypersomnia (HS)
Beyond the preview
Go deeper on NCT00983437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983437.